SUPPLEMENTARY MATERIAL
Lycopus europaeus: Phenolic fingerprint, antioxidant activity and antimicrobial effect on clinical Staphylococcus aureus strains
Silvia Fialováa,*, Lívia Slobodníkováb, Lucia Veizerovác and Daniel Grančaia
1Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovak Republic;
bInstitute of Microbiology, Faculty of Medicine, Comenius University and University Hospital in Bratislava, 811 08 Bratislava, Slovak Republic;
cDepartment of Pharmaceutical Analysis and Nuclear Pharmacy; Toxicological and Antidoping center, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovak Republic.
*Corresponding author. E-mail: fialova@fpharm.uniba.sk
Abstract
Lycopus europaeus L. leaves water extract (LEL) was submitted to phytochemical analysis, and evaluated for its antibacterial and antioxidant effects. Antibacterial activity testing was performed on Staphylococcus aureus clinical strains from catheter-related and skin infections by broth microdilution test. LEL showed bactericidal activity at concentrations from 2500 to 5000 μg/mL against all, including methicillin resistant and polyresistant nosocomial strains. Antioxidant activity was examined using DPPH and ABTS (11.3 and 9.8 μg/ml resp.) and by FRAP method (891μmol AAE/g dry extract). Phytochemical analysis of LEL was performed by LC-DAD-MS/MS. Ten phenolic compounds were identified; two minor compounds (glucopyranosyl rosmarinic acid and sagerinig acid) have not been described in Lycopus yet. The major compounds, considered to be responsible for biological activities detected in the study, were determined as rosmarinic acid (76 mg/g) and luteolin-7-O-glucuronide (23 mg/g). L. europaeus arises from our study as a promising source of antibacterial agents for topical usage.
Keywords: Lycopus; phenolics; antioxidant; antimicrobial;
Experimental
Plant Material
Aerial parts of Lycopus europaeus were collected from The Garden of Medical Plants, Faculty of Pharmacy in Bratislava. Harvested plant was 2 years old and was collected at the flowering time. The leaves were separated from the stems and flowers and dried at 32 – 35 °C. A voucher specimen (LE11ZLR) has been deposited at the Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.
Extraction
Water extract of dried leaves of L. europaeus was prepared according to Pharmacopoea Bohemoslovaca 4th edition (1987). The infusion was lyophilised; the yield was 10.40 %.
General Experimental Procedures
Disk-diffusion method on Mueller-Hinton agar medium (OXOID, Great Britain) was used for detection of antimicrobial susceptibility of S. aureus strains to oxacillin, gentamicin, ciprofloxacin, vancomycin, cotrimoxazole, erythromycin and clindamycin, using commercial antibiotic disks (OXOID, Great Britain; CLSI 2009a). The susceptibility test results were interpreted according to the CLSI guidelines (CLSI 2010). Resistance to methicillin/oxacillin was confirmed by Penicillin Binding Protein 2a latex agglutination test (OXOID, Great Britain).
The minimal inhibitory (MIC) and minimal bactericidal concentrations (MBC) of LEL were tested by broth microdilution assay according to the CLSI (CLSI 2009b). LEL for antimicrobial activity testing was dissolved in sterile aqua pro injectione and filtration-sterilized. Serial geometric dilutions from 5000 to 156 µg.mL-1 were prepared in the Mueller-Hinton Broth (OXOID, Great Britain). All tests were performed in three independent runs.
The LC-MS analyses were performed on an Agilent 1260 Infinity LC System (Agilent Technologies, Germany), equipped with a binary pump, an autosampler, a column thermostat, and a diode array detector (DAD), coupled to a quadrupole-time of flight (6520 Accurate-Mass QTOF) instrument equipped with an orthogonal ESI source (Agilent Technologies, Germany). HPLC separation of LEL was carried out on a Hypersil BDS-C18 column (4.0×250mm, 5µm, Agilent Technologies, Germany) at 35°C and a flow rate of 0.4 mL/min. Water (pH 2.8 with HOAc) and MeCN were used as mobile phase A and B respectively. The following gradient program was used: 10% B (20 min), 20% B (25 min), 60% (50 min), 95% (62 min) and 10% (70 min). The ESI ion source parameters were as follows: capillary voltage: 3.5 kV, nebulizer: 40 psi (N2), dry gas flow: 10 L/min (N2), and dry temperature: 300 °C. The mass spectrometer was operated in an autoMS2 mode where each negative ion MS scan (m/z 100-3000, average of 4 spectra) was followed by MS2 scans (m/z 100-3000, average of 4 spectra, isolation window of 4 amu, collision energy 20 eV) of the two most intense precursor ions. Ions were excluded from analyses for 0.5 min after two MS2 spectra had been acquired. Nitrogen was used as collision gas.
The UV wavelengths used for determining the phenolic compounds were 280 nm for flavonoids and 320 nm for phenolic acids. Phenolic compounds were identified by comparing their UV and mass spectra with literature and authentic standards when available and by measuring accurate m/z. The quantitative determination of LEL components was provided by the method of external standards. We used luteolin-7-O-glucoside for determination of flavonoids and rosmarinic acid for determination of phenolic acids. Chromatographic standards and standards of free radicals were purchased from Sigma-Aldrich, Germany.
Radical scavenging activities determined by decolorization of 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) were measured spectrophotometrically (Nagy et al. 2006). The sample (200 μL) with 1.8 mL of DPPH solution (55 μmol) was incubated at room temperature for 30 min. The absorbance was read against a blank at 517 nm. The ABTS, 2,2 azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radical cation decolorization assay was carried out, using an improved ABTS decolorization assay of Re et al. (1999). For the study the ABTS•+ solution was diluted with ethanol to an absorbance of 0.70 (± 0.02) at 734 nm and equilibrated at 30 °C. After addition of 2 mL of diluted ABTS solution to 20 μL of sample, the absorbance reading was taken exactly 6 min after initial mixing. Ferric-reducing antioxidant power assay (FRAP) was carried out according to the procedure of Benzie & Strain (1996). Briefly, the FRAP reagent was prepared from acetate buffer 300 mmol/L (pH 3.6), 10 mmol/L TPTZ solution in 40 mmol/L HCl and 20 mmol/L FeCl3 × 6 H2O. The FRAP reagent was prepared fresh daily. Fifty microliters of sample were added to 1.5 mL of the FRAP reagent. The absorbance of the reaction mixture was recorded at 593 nm after 5 min. The standard curve was linear between 100 and 1000 μmol ascorbic acid (AA). Results are expressed as ascorbic acid equivalents (AAE) in μmol AAE/g dry mass. All determinations were performed in triplicate.
Bacterial strains
Thirty-one clinical S. aureus strains and two cultures collection strains (ATCC 29213, and ATCC 43300) were included in the study. The clinical strains were isolated from infections associated with central venous, wound, and respiratory suction catheters, and from skin lesions of patients with atopic dermatitis and impetigo (Table S1). The strains were preserved in Brain-Heart Infusion with 20% glycerol at -20 °C and before the analysis were cultivated overnight at 37 °C on blood agar.
Table S1. Lycopus europaeus water infusion activity on clinical Staphylococcus aureus strains.
Strain
|
Origin
|
Antimicrobial susceptibility
|
LEL MIC
[g.mL-1]
|
LEL MBC
[g.mL-1]
|
OXA
|
GEN
|
CIP
|
VAN
|
COT
|
ERY
|
CLI
|
1
|
CVC
|
R
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
2
|
CVC
|
R
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
3
|
CVC
|
S
|
S
|
R
|
S
|
S
|
S
|
S
|
5000
|
5000
|
4
|
CVC
|
R
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
5
|
CVC
|
S
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
6
|
CVC
|
R
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
7
|
CVC
|
R
|
R
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
8
|
CVC
|
S
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
9
|
WDC
|
S
|
S
|
S
|
S
|
S
|
R
|
R
|
2500
|
2500
|
10
|
WDC
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
5000
|
5000
|
11
|
WDC
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
5000
|
5000
|
12
|
WDC
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
2500
|
2500
|
13
|
WDC
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
5000
|
5000
|
15
|
RSC
|
R
|
S
|
R
|
S
|
R
|
R
|
R
|
2500
|
2500
|
16
|
RSC
|
R
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
13
|
RSC
|
S
|
S
|
S
|
S
|
S
|
R
|
R
|
2500
|
2500
|
14
|
ADL
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
2500
|
5000
|
15
|
ADL
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
2500
|
2500
|
16
|
ADL
|
S
|
R
|
R
|
S
|
S
|
S
|
S
|
2500
|
2500
|
17
|
ADL
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
5000
|
5000
|
18
|
ADL
|
S
|
R
|
S
|
S
|
S
|
R
|
R
|
2500
|
2500
|
19
|
ADL
|
S
|
S
|
S
|
S
|
S
|
R
|
S
|
2500
|
2500
|
20
|
ADL
|
R
|
S
|
R
|
S
|
S
|
R
|
R
|
2500
|
2500
|
21
|
ADL
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
2500
|
2500
|
22
|
ADL
|
S
|
S
|
S
|
S
|
S
|
R
|
R
|
2500
|
2500
|
23
|
ADL
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
2500
|
2500
|
24
|
IMP
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
5000
|
5000
|
25
|
IMP
|
S
|
S
|
S
|
S
|
S
|
S
|
S
|
2500
|
2500
|
26
|
IMP
|
R
|
S
|
R
|
S
|
S
|
R
|
S
|
2500
|
5000
|
27
|
IMP
|
R
|
R
|
R
|
S
|
S
|
R
|
S
|
2500
|
5000
|
28
|
IMP
|
S
|
S
|
S
|
S
|
S
|
R
|
R
|
2500
|
5000
|
ATCC 43300
|
R
|
|
|
|
|
|
|
2500
|
2500
|
ATCC 29213
|
S
|
|
|
|
|
|
|
5000
|
5000
|
CVC – central venous catheter; WDR - wound drainage catheter; RSC - respiratory suction catheter; ADL – atopic dermatitis skin lesion; IMP – impetigo; OXA – oxacillin; GEN – gentamicin; CIP – ciprofloxacin; VAN – vancomycin; COT – cotrimoxazole; ERY – erythromycin; CLI – clindamycin; LEL – Lycopus europaeus leaves water infusion; MIC – minimal inhibitory concentration; MBC – minimal bactericidal concentration; S – susceptible; R – resistant
Table S2. Free radicals scavenging activity of L. europaeus leaves water extract and its major containing compound rosmarinic acid, in comparison to standard antioxidant – ascorbic acid.
|
SC50 DPPH (μg.mL-1)a
|
SC50 ABTS (μg.mL-1)a
|
LEL water extract
|
11.27 ± 0.06
|
9.81 ± 0.32
|
Rosmarinic acid
|
1.70 ± 0.07
|
2.10 ± 0.05
|
Ascorbic acid
|
1.65 ± 0.06
|
1.00 ± 0.02
|
aValues are presented as means ± standard deviation (n=3)
SC50 - 50% scavenging concentration
Table S3. Flavonoids and caffeic acid derivatives of L. europaeus leaves water extract, their corresponding retention times (TR), molecular ions [M-H] and MS2 fragments in LC-MS analysis and quantitative abundance of polar phenolic compounds (mg.g-1) in L. europaeus water extract.
Compound
|
TR (min)
|
[M-H]
|
MS-MS (20eV)
|
Mass concentration (mg.g-1)*
|
1. Protocatechuic aldehyde
|
16.1
|
137.0243
|
108.0214
119.0130
|
< LOQ
|
2. Caffeic acid
|
21.9
|
179.0357
|
135.0441
| -
± 0.10
|
3. Quercetin-7-O-glucuronide
|
32.5
|
477.0689
|
301.0367
|
insufficient resolution
|
4. Lithospermic acid
|
33.3
|
537.1058
|
197.0441
179.0367
161.0247
|
2,18 ± 0.05
|
5. Luteolin-7-O-glucuronide
|
35.2
|
461.0745
|
285.0415
|
23.2 ± 2.14
|
6. Glucopyranosyl rosmarinic acid
|
35.9
|
521.1357
|
161.0267
359.0787
|
3.60 ± 0.16
|
7. Sagerinic acid
|
36.9
|
719.1638
|
359.0791
161.0273
|
1.95 ± 0.08
|
8. Luteolin-7-O-glucoside
|
38.0
|
447.0954
|
285.0421
|
< LOQ
|
9. Apigenin-7-O-glucuronide
|
40.1
|
445.0785
|
269.0471
|
1.22 ± 0.06
|
10. Rosmarinic acid
|
41.9
|
359.0789
|
161.0265
197.0491
179.0363
|
76.3 ± 4.34
|
*Values (mg.g-1 dry extract) are presented as means ± standard deviation (n=3), External standards: luteolin-7-O-glucoside (used for flavonoids determination), rosmarinic acid (used for phenolic acids determination), LOQ – limit of quantification
Figure S1. Total Ion Current (TIC) chromatogram of L. europaeus leaves water extract from the ESI-MS in negative mode. 1: protocatechuic aldehyde; 2: caffeic acid; 3: quercetin 7 O glucuronide; 4: lithospermic acid; 5: luteolin-7-O-glucuronide; 6: glucopyranosyl rosmarinic acid; 7: sagerinic acid; 8: luteolin-7-O-glucoside; 9: apigenin-7-O-glucuronide; 10: rosmarinic acid.
Figure S2. LC-ESI-MS2 mass spectra of glucopyranosyl rosmarinic acid in L. europaeus leaves water extract.
Figure S3. LC-ESI-MS2 mass spectra of sagerinic acid in L. europaeus leaves water extract.
References
Benzie, I.F.F. & Strain, J.J. (1996). The Ferric Reducing Ability of Plasma (FRAP) as a
Measure of ‘‘Antioxidant Power’’: The FRAP Assay. Analytical biochemistry, 239, 70-76.
Clinical and Laboratory Standards Institute. (2009a). Performance standards for antimicrobial disk susceptibility tests; Approved standard - Tenth edition. CLSI Document M2-A10.Wayne, Pennsylvania, USA.
Clinical and Laboratory Standards Institute. (2009b). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard – Eight edition. CLSI Document M07-A8. Wayne, Pennsylvania, USA.
Clinical and Laboratory Standards Institute. (2010). Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI Document M100-S20. Wayne, Pennsylvania, USA.
Nagy, M., Spilková, J., Vrchovská, V., Kontšeková, Z., Šeršeň, F., Mučaji, P. & Grančai, D. (2006). Free radical scavenging activity of different extracts and some constituents from the leaves of Ligustrum vulgare and L. delavayanum. Fitoterapia, 77, 395-397.
Pharmacopoea Bohemoslovaca PhBs IV. (1987). Praha: Avicenum.
Re, R., Pellegrini, N., Proteggente, A., Pannala, A., Yang, M. & Rice-Evans, C. (1999). Antioxidant activity applying an inproved ABTS radical cation decolorization assay. Free Radical Biology & Medicine, 26, 1231-1237.
|